TY - JOUR
T1 - A systematic review of Nipah virus disease epidemiological parameters, outbreaks, and mathematical models
AU - Naidoo, Tristan
AU - Morgenstern, Christian
AU - Doohan, Patrick
AU - Earl, Rhys
AU - Rawson, Thomas
AU - Sheppard, Richard J.
AU - Hicks, Joseph
AU - Radhakrishnan, Sreejith
AU - Johnson, Rob
AU - Hartner, Anna Maria
AU - Cattarino, Lorenzo
AU - McCain, Kelly
AU - Vicco, Anna
AU - Imai-Eaton, Natsuko
AU - Elsland, Sabine van
AU - Cori, Anne
AU - McCabe, Ruth
AU - Bhatia, Sangeeta
AU - the Pathogen Epidemiology Review Group
N1 - Publisher Copyright:
© 2026 Elsevier Ltd
PY - 2026
Y1 - 2026
N2 - Our systematic review, based on PRISMA guidelines (PROSPERO CRD42023393345), characterised the epidemiology, outbreaks, and mathematical models of Nipah virus, an important public health threat in south and southeast Asia. We searched PubMed and Web of Science from database inception to March 14, 2025, and extracted 243 parameters, 89 risk factors, 39 models, and 23 distinct outbreaks from 119 papers. IgG seroprevalence estimates in the general population ranged from 0% to 12·5%. Nipah virus causes severe disease, with pooled case–fatality ratio estimates ranging widely from 9·1% (95% CI 0·2–41·3) in Singapore to 81·9% (95% CI 71·9–88·9) in Bangladesh. The infection timeline and clinical course of Nipah virus remain poorly characterised; we estimated a median incubation period of 8·77 days (165, 95% CI 7·53–10·02) from eight estimates in seven articles with sufficient information. Transmission parameter estimates were scarce, and all but one of five central estimates of the basic reproduction number were less than one. Nipah virus mathematical models (39) were rarely fitted to data (eight). All extracted information is accessible via our R package, epireview.
AB - Our systematic review, based on PRISMA guidelines (PROSPERO CRD42023393345), characterised the epidemiology, outbreaks, and mathematical models of Nipah virus, an important public health threat in south and southeast Asia. We searched PubMed and Web of Science from database inception to March 14, 2025, and extracted 243 parameters, 89 risk factors, 39 models, and 23 distinct outbreaks from 119 papers. IgG seroprevalence estimates in the general population ranged from 0% to 12·5%. Nipah virus causes severe disease, with pooled case–fatality ratio estimates ranging widely from 9·1% (95% CI 0·2–41·3) in Singapore to 81·9% (95% CI 71·9–88·9) in Bangladesh. The infection timeline and clinical course of Nipah virus remain poorly characterised; we estimated a median incubation period of 8·77 days (165, 95% CI 7·53–10·02) from eight estimates in seven articles with sufficient information. Transmission parameter estimates were scarce, and all but one of five central estimates of the basic reproduction number were less than one. Nipah virus mathematical models (39) were rarely fitted to data (eight). All extracted information is accessible via our R package, epireview.
U2 - 10.1016/S1473-3099(26)00239-2
DO - 10.1016/S1473-3099(26)00239-2
M3 - Review
C2 - 42447883
AN - SCOPUS:105045120284
SN - 1473-3099
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
ER -